Evidence map›Paper›PMID 37244674›Full record

ArticleThe Lancet. Public health2023

Adverse childhood experiences and adolescent cannabis use trajectories: findings from a longitudinal UK birth cohort.

Lindsey A Hines, Hannah J Jones, Matthew Hickman, Michael Lynskey, Laura D Howe, Stan Zammit, Jon Heron

Abstract read
In one paragraph

Article in The Lancet. Public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Childhood Sexual Trauma, Substance Use, and Antiretroviral Therapy Adherence Among Older Adults Living With HIV: A Mediational Analysis.Journal of applied gerontology : the official journal of the Southern Gerontological Society · 2025
    Article
  9. The Developmental Trajectory to Cannabis Use Disorder.The American journal of psychiatry · 2024
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lindsey A HinesDepartment of Psychology, University of Bath, Bath, UK; Bristol Medical School, University of Bristol, Bristol, UK; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. Electronic address: lh2461@bath.ac.uk.
Hannah J JonesCentre for Academic Mental Health, Bristol Medical School, University of Bristol, Bristol, UK; UK Medical Research Council (MRC) Integrative Epidemiology Unit at the University of Bristol, Bristol, UK; UK NIHR Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust, University of Bristol, Bristol, UK.
Matthew HickmanPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Michael LynskeyDrug Science, London, UK.
Laura D HowePopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; UK Medical Research Council (MRC) Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.
Stan ZammitCentre for Academic Mental Health, Bristol Medical School, University of Bristol, Bristol, UK; Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, UK.
Jon HeronCentre for Academic Mental Health, Bristol Medical School, University of Bristol, Bristol, UK; UK Medical Research Council (MRC) Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.

Funding

Department of HealthMedical Research Council G9815508Medical Research Council MC_PC_15018Medical Research Council MC_PC_19009Medical Research Council MR/L010305/1Medical Research Council MR/L022206/1Medical Research Council MR/M006727/1Medical Research Council MR/M020894/1Medical Research Council MR/N00616X/1Wellcome TrustWellcome Trust 209158/Z/17/ZWellcome Trust 217065/Z/19/Z
6 · The paper itself

Abstract

backgroundAdverse childhood experiences (ACEs) are classically defined as physical abuse, sexual abuse, emotional abuse, emotional neglect, bullying, parental substance use or abuse, violence between parents, parental mental health problems or suicide, parental separation, or a parent convicted of criminal offence. Exposure to ACEs can be associated with cannabis use, but no comparisons across all adversities have been made while also considering timing and frequency of cannabis use. We aimed to explore the association between ACEs and cannabis use timing and frequency in adolescence, considering the cumulative number of ACEs and individual ACEs.

methodsWe used data from the Avon Longitudinal Study of Parents and Children, a longitudinal UK birth cohort study. Longitudinal latent classes of cannabis use frequency were derived from self-reported data at multiple timepoints in participants aged 13-24 years. ACEs between ages 0 years and 12 years were derived from prospective and retrospective reports at multiple timepoints by parents and the participant. Multinomial regression was used to analyse the effect of both cumulative exposure to all ACEs and the ten individual ACEs on cannabis use outcomes.

findings5212 participants (3132 [60·0%] were female and 2080 [40·0%] were male; 5044 [96·0%] were White and 168 [4·0%] were Black, Asian, or minority ethnic) were included in this study. After adjustment for polygenic risk and environmental risk factors, participants who had 4 or more ACEs at age 0-12 years were at increased risk of early persisting regular cannabis use (relative risk ratio [RRR] 3·15 [95% CI 1·81-5·50]), later onset regular use (1·99 [1·14-3·74]), and early persisting occasional use (2·55 [1·74-3·73]) compared with low or no cannabis use. After adjustment, early persisting regular use was associated with parental substance use or abuse (RRR 3·90 [95% CI 2·10-7·24]), parental mental health problems (2·02 [1·26-3·24]), physical abuse (2·27 [1·31-3·98]), emotional abuse (2·44 [1·49-3·99]), and parental separation (1·88 [1·08-3·27]) compared with low or no cannabis use.

interpretationRisks for problematic adolescent cannabis use are highest for individuals reporting 4 or more ACEs, and were particularly raised for those with parental substance use or abuse. Public health measures to address ACEs might reduce adolescent cannabis use.

fundingThe Wellcome Trust, UK Medical Research Council, Alcohol Research UK.

Indexed as

Adverse Childhood ExperiencesCannabisSubstance-Related DisordersAdolescentBirth CohortChildChild, PreschoolCohort StudiesFemaleHumansInfantInfant, NewbornLongitudinal StudiesMaleProspective StudiesRetrospective Studies

Identifiers

PMID37244674
PMCPMC10751739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.